𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Echogenic kidneys and medullary calcium deposition in a young child with Glycogen Storage Disease type 1a

✍ Scribed by J. J. A. Fick; F. J. A. Beek

Publisher
Springer-Verlag
Year
1992
Tongue
English
Weight
482 KB
Volume
22
Category
Article
ISSN
0301-0449

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Novel mutation (G188R) in the G6Pase gen
Novel mutation (G188R) in the G6Pase gene of a patient with glycogen storage disease type 1a
✍ Pascale Trioche; Philippe Labrune; Michel OdiΓ¨vre; Michelle Hedchouel; Jean-Fran πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 286 KB πŸ‘ 2 views

Germline mutations in the BRCAl gene confer susceptibility to hereditary breast and ovarian cancer (Easton et al., 1993; Ford et al., 1994). We report a new mutation in the BRCAl gene in an Austrian hereditary breast and ovarian cancer (HBOC) family with four breast cancer cases and one ovarian canc

Medullary cystic kidney disease with hyp
Medullary cystic kidney disease with hyperuricemia and gout in a large Cypriot family: No allelism with nephronophthisis type 1
✍ Stavrou, Christoforos; Pierides, Alkis; Zouvani, Ioanna; Kyriacou, Kyriacos; Ant πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 46 KB πŸ‘ 2 views

We describe a large Cypriot family with an interstitial type of nephropathy, inherited as an autosomal dominant trait that led to end stage renal failure between 51 to 78 years of age (mean 62.2 years). Twenty-three people are known to be affected, but several younger relatives with normal renal fun

The identification of five novel mutatio
The identification of five novel mutations in the lysosomal acid a-(1,4) glucosidase gene from patients with glycogen storage disease type II
✍ Clare E. Beesley; Anne H. Child; Magdi H. Yacoub πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 165 KB πŸ‘ 2 views

The autosomal recessive disorder Glycogen Storage Disease Type II (GSDII) is caused by a deficiency in the lysosomal enzyme acid -glucosidase. We have optimised a procedure to use fluorescent DNA sequencing technology to screen for mutations within the -glucosidase gene from UK patients with GSDII.